Browsing Institutt for helse og samfunn by Author "Abrahamsen, Bo"

Now showing items 1-4 of 4

  • Anti-osteoporosis drug use: too little, too much, or just right? The HUNT study, Norway 
    Hoff, Mari; Skurtveit, Svetlana; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Skovlund, Eva; Abrahamsen, Bo; Forsmo, Siri; Schei, Berit (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2018)
    Summary: Use of anti-osteoporotic drugs (AODs) was examined in a Norwegian population 50–85 years. Among them with Fracture Risk Assessment Tool (FRAX) score for major osteoporotic fracture ≥ 20, 25% of the women and 17% ...
  • Does treatment with bisphosphonates protect against fractures in real life? The HUNT study, Norway 
    Hoff, Mari; Skovlund, Eva; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Holvik, Kristin; Abrahamsen, Bo; Schei, Berit (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2021)
    Summary Bisphosphonates reduce fractures in randomized controlled trials (RCT); however, there is less information from real life. In our population including 14,990 women and 13,239 men, use of bisphosphonates reduced ...
  • Explaining declining hip fracture rates in Norway: a population-based modelling study 
    Kjeldgaard, Helena Kames; Holvik, Kristin; Abrahamsen, Bo; Tell, Grethe S.; Meyer, Haakon E.; O’Flaherty, Martin (Journal article / Tidsskriftartikkel / PublishedVersion; Peer reviewed, 2023)
    Background Although age-standardised hip fracture incidence has declined in many countries during recent decades, the number of fractures is forecast to increase as the population ages. Understanding the drivers behind ...
  • Proton pump inhibitors and fracture risk. The HUNT study, Norway. 
    Hoff, Mari; Skovlund, Eva; Skurtveit, Svetlana; Meyer, Haakon E; Langhammer, Arnulf; Søgaard, Anne-Johanne; Syversen, Unni; Forsmo, Siri; Abrahamsen, Bo; Schei, Berit (Journal article / Tidsskriftartikkel / AcceptedVersion; Peer reviewed, 2020)
    Summary Proton pump inhibitors (PPIs) have been linked to increased risk of fracture; the data have, however, been diverging. We did not find any increased risk of fractures among users of PPIs in a Norwegian population ...